475 related articles for article (PubMed ID: 27818347)
1. Evaluation of the Tobacco Heating System 2.2. Part 7: Systems toxicological assessment of a mentholated version revealed reduced cellular and molecular exposure effects compared with mentholated and non-mentholated cigarette smoke.
Kogel U; Titz B; Schlage WK; Nury C; Martin F; Oviedo A; Lebrun S; Elamin A; Guedj E; Trivedi K; Ivanov NV; Vanscheeuwijck P; Peitsch MC; Hoeng J
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S123-S138. PubMed ID: 27818347
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke.
Oviedo A; Lebrun S; Kogel U; Ho J; Tan WT; Titz B; Leroy P; Vuillaume G; Bera M; Martin F; Rodrigo G; Esposito M; Dempsey R; Ivanov NV; Hoeng J; Peitsch MC; Vanscheeuwijck P
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S93-S122. PubMed ID: 27818348
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke.
Wong ET; Kogel U; Veljkovic E; Martin F; Xiang Y; Boue S; Vuillaume G; Leroy P; Guedj E; Rodrigo G; Ivanov NV; Hoeng J; Peitsch MC; Vanscheeuwijck P
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S59-S81. PubMed ID: 27793746
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke.
Sewer A; Kogel U; Talikka M; Wong ET; Martin F; Xiang Y; Guedj E; Ivanov NV; Hoeng J; Peitsch MC
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S82-S92. PubMed ID: 27866933
[TBL] [Abstract][Full Text] [Related]
5. A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. II. Systems toxicology assessment.
Titz B; Kogel U; Martin F; Schlage WK; Xiang Y; Nury C; Dijon S; Baumer K; Peric D; Bornand D; Dulize R; Phillips B; Leroy P; Vuillaume G; Lebrun S; Elamin A; Guedj E; Trivedi K; Ivanov NV; Vanscheeuwijck P; Peitsch MC; Hoeng J
Food Chem Toxicol; 2018 May; 115():284-301. PubMed ID: 29545142
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2.
Martin F; Talikka M; Ivanov NV; Haziza C; Hoeng J; Peitsch MC
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S151-S157. PubMed ID: 27845159
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program.
Smith MR; Clark B; Lüdicke F; Schaller JP; Vanscheeuwijck P; Hoeng J; Peitsch MC
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S17-S26. PubMed ID: 27450400
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Tobacco Heating System 2.2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2.2 aerosol.
Schaller JP; Pijnenburg JPM; Ajithkumar A; Tricker AR
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S48-S58. PubMed ID: 27793747
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol.
Schaller JP; Keller D; Poget L; Pratte P; Kaelin E; McHugh D; Cudazzo G; Smart D; Tricker AR; Gautier L; Yerly M; Reis Pires R; Le Bouhellec S; Ghosh D; Hofer I; Garcia E; Vanscheeuwijck P; Maeder S
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S27-S47. PubMed ID: 27720919
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland.
Haziza C; de La Bourdonnaye G; Skiada D; Ancerewicz J; Baker G; Picavet P; Lüdicke F
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S139-S150. PubMed ID: 27816672
[TBL] [Abstract][Full Text] [Related]
11. A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathology.
Phillips BW; Schlage WK; Titz B; Kogel U; Sciuscio D; Martin F; Leroy P; Vuillaume G; Krishnan S; Lee T; Veljkovic E; Elamin A; Merg C; Ivanov NV; Peitsch MC; Hoeng J; Vanscheeuwijck P
Food Chem Toxicol; 2018 Jun; 116(Pt B):388-413. PubMed ID: 29654848
[TBL] [Abstract][Full Text] [Related]
12. An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes.
Phillips B; Veljkovic E; Boué S; Schlage WK; Vuillaume G; Martin F; Titz B; Leroy P; Buettner A; Elamin A; Oviedo A; Cabanski M; De León H; Guedj E; Schneider T; Talikka M; Ivanov NV; Vanscheeuwijck P; Peitsch MC; Hoeng J
Toxicol Sci; 2016 Feb; 149(2):411-32. PubMed ID: 26609137
[TBL] [Abstract][Full Text] [Related]
13. Comparative systems toxicology analysis of cigarette smoke and aerosol from a candidate modified risk tobacco product in organotypic human gingival epithelial cultures: A 3-day repeated exposure study.
Zanetti F; Titz B; Sewer A; Lo Sasso G; Scotti E; Schlage WK; Mathis C; Leroy P; Majeed S; Torres LO; Keppler BR; Elamin A; Trivedi K; Guedj E; Martin F; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
Food Chem Toxicol; 2017 Mar; 101():15-35. PubMed ID: 28025120
[TBL] [Abstract][Full Text] [Related]
14. Investigating a toxic risk (self-inflicted) the example of conventional and advanced studies of a novel Tobacco Heating System.
Dayan AD
Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S15-S16. PubMed ID: 27483981
[TBL] [Abstract][Full Text] [Related]
15. A six-month systems toxicology inhalation/cessation study in ApoE
Phillips B; Szostak J; Titz B; Schlage WK; Guedj E; Leroy P; Vuillaume G; Martin F; Buettner A; Elamin A; Sewer A; Sierro N; Choukrallah MA; Schneider T; Ivanov NV; Teng C; Tung CK; Lim WT; Yeo YS; Vanscheeuwijck P; Peitsch MC; Hoeng J
Food Chem Toxicol; 2019 Apr; 126():113-141. PubMed ID: 30763686
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes.
Jaccard G; Tafin Djoko D; Moennikes O; Jeannet C; Kondylis A; Belushkin M
Regul Toxicol Pharmacol; 2017 Nov; 90():1-8. PubMed ID: 28818540
[TBL] [Abstract][Full Text] [Related]
17. Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe -/- mice--a systems toxicology analysis.
Lo Sasso G; Titz B; Nury C; Boué S; Phillips B; Belcastro V; Schneider T; Dijon S; Baumer K; Peric D; Dulize R; Elamin A; Guedj E; Buettner A; Leroy P; Kleinhans S; Vuillaume G; Veljkovic E; Ivanov NV; Martin F; Vanscheeuwijck P; Peitsch MC; Hoeng J
Inhal Toxicol; 2016 Apr; 28(5):226-40. PubMed ID: 27027324
[TBL] [Abstract][Full Text] [Related]
18. 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product.
Iskandar AR; Mathis C; Martin F; Leroy P; Sewer A; Majeed S; Kuehn D; Trivedi K; Grandolfo D; Cabanski M; Guedj E; Merg C; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
ALTEX; 2017; 34(1):23-48. PubMed ID: 27388676
[TBL] [Abstract][Full Text] [Related]
19. Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells.
Poussin C; Laurent A; Peitsch MC; Hoeng J; De Leon H
Toxicology; 2016 Jan; 339():73-86. PubMed ID: 26655683
[TBL] [Abstract][Full Text] [Related]
20. Respiratory Effects of Exposure to Aerosol From the Candidate Modified-Risk Tobacco Product THS 2.2 in an 18-Month Systems Toxicology Study With A/J Mice.
Titz B; Sewer A; Luettich K; Wong ET; Guedj E; Nury C; Schneider T; Xiang Y; Trivedi K; Vuillaume G; Leroy P; Büttner A; Martin F; Ivanov NV; Vanscheeuwijck P; Hoeng J; Peitsch MC
Toxicol Sci; 2020 Nov; 178(1):138-158. PubMed ID: 32780831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
